CLVS Stock Price, News & Analysis
Company Description
CLVS (NASDAQ: CLVS) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $11.8M.
CLVS stock has declined 97.5% over the past year.
This page provides a comprehensive overview of CLVS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CLVS (CLVS) stock. Over the past 12 months, the stock has lost 97.5%. At a market capitalization of $11.8M, CLVS is classified as a micro-cap stock with approximately 145.0M shares outstanding.
Latest News
CLVS has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, earnings, conferences. View all CLVS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CLVS Company Profile & Sector Positioning
CLVS (CLVS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing CLVS often look at related companies in the same sector, including Xtl Biopharmaceu (XTLB), Soligenix Inc (SNGX), Leap Therapeutic (LPTX), Sensei Biotherapeutics, Inc. (SNSE), and Moleculin Biotec (MBRX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLVS's relative position within its industry.